Study Of Atopic Dermatitis In Pediatrics
NCT00257569 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 278
Last updated 2013-05-06
Summary
To verify of cetirizine dry syrup to ketotifen dry syrup in the change in the severity of pruritus of the treatment period.
Conditions
- Dermatitis, Atopic
Interventions
- DRUG
-
Cetirizine Dry Syrup
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
Countries
More Related Trials
-
A Study for HSK44459 in Participants With Atopic Dermatitis
NCT06996912 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
NCT02975206 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2
-
Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis
NCT02589392 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study of KHK4577
NCT02004119 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT04875169 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
NCT03356977 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT06116565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis
NCT06713499 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
NCT04539639 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
NCT01174511 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis
NCT05579925 ·Status: COMPLETED ·Phase: PHASE2
-
Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
NCT00535691 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
NCT06397781 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
NCT01782729 ·Status: COMPLETED ·Phase: PHASE4
-
Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
NCT01792713 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Topical Application to Prevent Atopic Dermatitis
NCT03871998 ·Status: COMPLETED ·Phase: NA
-
Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis
NCT04214197 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of a Combined Dermatological Treatment in Children With Atopic Dermatitis
NCT02920411 ·Status: COMPLETED ·Phase: NA
-
Verification Study of Ciclosporin for Atopic Dermatitis
NCT00232076 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
NCT00560326 ·Status: COMPLETED ·Phase: PHASE2
-
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
NCT03796676 ·Status: COMPLETED ·Phase: PHASE3
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
NCT05042258 ·Status: RECRUITING ·Phase: PHASE4
-
Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis
NCT06277765 ·Status: COMPLETED ·Phase: PHASE3